PMID: 6113309Jun 20, 1981Paper

Normal fertility in women with post-pill amenorrhoea

Lancet
M G HullH S Jacobs

Abstract

After exclusion of primary ovarian failure and causes of infertility not due to contraception 48 patients with post-pill amenorrhoea (PPA) and 47 patients whose amenorrhoea did not follow oral contraception received treatment aimed at inducing ovulation. In the patients with PPA the cumulative conception rate was 91% at 12 months from the start of treatment and 98% at 24 months. 80% gave birth to a child by 18 months and 95% by 30 months. These rates were similar to those of the non-PPA group and to previously published normal rates. Hence PPA poses no serious threat to fertility, unlike the tubal damage that may result from use of an intrauterine device. Whatever their previous menstrual history women, especially the nulliparous, who are concerned about their future fertility should be recommended oral contraception in preference to an intrauterine device.

References

May 12, 1979·British Medical Journal·M G HullH S Jacobs
Feb 4, 1978·British Medical Journal·M P VesseyP Wiggins
Apr 1, 1977·British Journal of Obstetrics and Gynaecology·S FranksJ D Nabarro
Oct 8, 1977·British Medical Journal·H S JacobsS Franks
Aug 10, 1974·Lancet·C Hougie, N Clarke
Nov 10, 1973·British Medical Journal·S J SteeleA Brett
Jan 1, 1969·Acta Obstetricia Et Gynecologica Scandinavica·U Larsson-Cohn
Mar 1, 1969·Social Biology·C F WestoffN B Ryder
Mar 14, 1981·British Medical Journal·M P VesseyK McPherson
Sep 29, 2011·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Ulla M ÅgrenEllen Mommers

❮ Previous
Next ❯

Citations

Jun 5, 1982·British Medical Journal·M G HullD R Bromham
Sep 1, 1982·British Journal of Obstetrics and Gynaecology·M H Soltan, K W Hancock
Apr 1, 1984·Clinical Endocrinology·J R DavisW J Jeffcoate
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Howard S. Jacobs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.